SCHEMBL9323405

SCHEMBL9323405

Cc1ccc(N(C)[C@@H]2C3CCN(CC3)[C@@H]2C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 18/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9322825 0.89 TACR1 (0.55) TACR1
SCHEMBL9323184 0.89 TACR1 (0.53) TACR1
SCHEMBL9323178 0.86 TACR1 (0.54) TACR1
SCHEMBL9325071 0.86 TACR1 (0.58) TACR1
SCHEMBL9767395 0.86 TACR1 (0.53) TACR1
SCHEMBL9325144 0.86 TACR1 (0.52) TACR1
SCHEMBL9324225 0.85 TACR1 (0.55) TACR1
SCHEMBL9325295 0.84 TACR1 (0.56) TACR1
SCHEMBL9322887 0.83 TACR1 (0.49) TACR1
SCHEMBL9325160 0.82 TACR1 (0.53) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed